ETF

Changing My Stance And Loading Up On SCHD (Archive)

Changing my stance as SCHD’s valuation, exposures and risk-reward skew turn compelling.

KCE: Why I'm Very Bullish On This Capital Markets ETF (Archive)

Rate-cut tailwinds and sector-wide deal revival make diversified KCE a compelling buy.

XPH: Revenue Challenges Ahead For U.S. Pharmaceuticals (Archive)

XPH faces looming patent cliffs and riskier orphan drug bets, pressuring future alpha.

OILK: Changing To A Bullish Stance (Archive)

Cautiously bullish on oil after OPEC+ cuts and China’s recovering demand and PMIs.

Why I Think JEPI Will Outperform SCHD (Archive)

JEPI’s portfolio better reflects my macro views than SCHD’s, especially on energy.

SCHD: Annual Portfolio Refresh Won't Help (Archive)

SCHD’s looming energy overweight risks turning dividend strength into cyclical performance drag.

EPOL: Inexpensive But Limited Bullish Tailwinds (Archive)

Cheaply valued EPOL faces energy and banking headwinds, warranting only a cautious hold.